Status:
COMPLETED
Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy
Lead Sponsor:
Transcend Medical, Inc.
Conditions:
Primary Open Angle Glaucoma (POAG)
Eligibility:
All Genders
21-99 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of CyPass implantation as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open angle glauco...
Eligibility Criteria
Inclusion
- Diagnosis of POAG
- Medicated IOP ≥ 21 and ≤ 35 mmHg
- Use of 1 - 4 topical IOP lowering medications
Exclusion
- Acute angle closure, traumatic, congenital, malignant, uveitic or neovascular glaucoma
- Use of oral hypotensive medication treatment for glaucoma
- Previous incisional glaucoma surgery, or any combined cataract-glaucoma procedure
- Clinically significant ocular pathology other than POAG
Key Trial Info
Start Date :
February 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01166659
Start Date
February 1 2010
End Date
May 1 2014
Last Update
May 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.